Posts by: Steve Bryson PhD

Steve Bryson PhD

Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.

February 15, 2021February 15, 2021

Tobramycin, Inhaled Antibiotic, Eases Symptoms, Study in Off-label Use Finds

News

Off-label use of the inhaled antibiotic tobramycin lowered sputum production, and eased shortness of breath, and cough in people with bronchiectasis, a small real-world study found. Although there was no ... Read more

September 4, 2020September 4, 2020

Case Study Reports COVID-19 Plus Rare Bacterial Infection in Bronchiectasis Patient

News

The presence of a rare bacterial infection plus COVID-19 was described for the first time in a young bronchiectasis patient with vitamin D3 deficiency, a case study reported. The patient was ... Read more

August 31, 2020August 31, 2020

Analysis Links Pneumonia With Bronchiectasis to Less Mortality, More Infections

News

People with bronchiectasis who acquire pneumonia in the community have fewer co-existing medical conditions and lower in-hospital mortality — but spend more time hospitalized and experience more Pseudomonas aeruginosa infections ... Read more

August 24, 2020August 24, 2020

Inflammatory Biomarkers Linked to More Severe Disease in COPD With Bronchiectasis

News

People with chronic obstructive pulmonary disease (COPD) have higher levels of inflammatory biomarkers if they also have bronchiectasis, or damage to the lung’s airways, according to a new study. Such ... Read more

August 17, 2020August 17, 2020

Use of Airway Clearance Techniques Rises With Flares and Infections

News

People with bronchiectasis and a productive cough are more likely to use airway clearance techniques (ACTs) if they experienced exacerbations and were hospitalized due to lung infections, a study revealed. The ... Read more

July 20, 2020July 20, 2020

Low Bacterial Diversity in Lungs Tied to Damaging Enzyme in Bronchiectasis

News

A low diversity of bacterial species in the lungs of adults with bronchiectasis is linked with higher levels of an enzyme called active neutrophil elastase (NE), as well as greater ... Read more

May 18, 2020May 18, 2020

Antibiotic Cayston Effective for Some Bronchiectasis Symptoms but Not All, Study Says

News

Treatment with the inhaled antibiotic Cayston (aztreonam lysine) reduced cough and sputum production, but was not effective against breathlessness and wheezing in people with bronchiectasis, according to an analysis of two clinical ... Read more

April 13, 2020April 13, 2020

Bronchiectasis in HIV Patients Can Be Misdiagnosed, Poorly Treated

News

People with bronchiectasis who also have human immunodeficiency virus (HIV) are often misdiagnosed, rarely referred to lung specialists, and not offered bronchodilator therapies, a small series of reports covering 14 patients found. ... Read more

January 23, 2020January 23, 2020

HTLV-1 Infection Linked to Bronchiectasis in Indigenous Adults in Central Australia

News

Infection with the human T-cell leukemia virus type 1 (HTLV-1) was identified as a risk factor for bronchiectasis, and one previously unknown, among indigenous adults in central Australia, a case-controlled study ... Read more

January 2, 2020January 2, 2020

Bronchiectasis Patients in Korea Have Higher Mortality Risk Due to Lung Disease and Cancer, Analysis Reveals

News

The risk for all-cause mortality and death related to respiratory conditions and lung cancer is significantly higher in patients with bronchiectasis compared to those without the lung disease, according to ... Read more